National Health Investors (NYSE:NHI) Shares Down 5.2% – Here’s What Happened

Shares of National Health Investors, Inc. (NYSE:NHI) dropped 5.2% during mid-day trading on Tuesday . The stock traded as low as $69.91 and last traded at $70.2830. 35,506 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 433,820 shares. The stock had previously closed at $74.15.

More National Health Investors News

Here are the key news stories impacting National Health Investors this week:

• Positive Sentiment: NHI raised its quarterly dividend 2.2% to $0.94 per share, supporting an annualized yield of roughly 5.3% at recent prices. The increase signals management’s confidence in recurring cash flow and enhances the stock’s appeal to income-focused investors. National Health Investors raises quarterly dividend
• Positive Sentiment: Management outlined plans to pursue approximately $500 million to $700 million of annual acquisitions while targeting net debt of about 4.1 times adjusted EBITDA. The strategy is intended to expand the healthcare real estate portfolio without materially increasing leverage. NHI acquisition and leverage targets
• Positive Sentiment: The company is emphasizing growth in its senior housing operating portfolio, or SHOP, which could provide stronger organic revenue and net operating income growth than traditional triple-net properties. National Health Investors SHOP growth
• Neutral Sentiment: Second-quarter revenue increased 1.6% year over year to $121.32 million, while reported earnings were $1.19 per share versus $1.22 a year earlier. The results show stable operations but limited near-term earnings growth. NHI second-quarter 2026 results
• Negative Sentiment: NHI set 2026 EPS guidance at $4.74 to $4.79, below the roughly $4.87 analyst consensus cited in the report. The guidance gap, combined with year-over-year EPS pressure, helps explain the earnings-related selloff and remains the main headwind for the stock. National Health Investors earnings dip

Analyst Ratings Changes

A number of research analysts have issued reports on NHI shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Truist Financial dropped their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. BMO Capital Markets cut their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday, June 15th. Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Finally, Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

National Health Investors Trading Up 1.3%

The company has a market cap of $3.48 billion, a PE ratio of 20.48, a price-to-earnings-growth ratio of 3.21 and a beta of 0.51. The company’s 50 day simple moving average is $75.17 and its two-hundred day simple moving average is $79.43. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The firm had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 11.01%. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.77 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be given a $0.92 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is presently 106.36%.

Insider Activity

In other National Health Investors news, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction on Friday, June 5th. The stock was bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in National Health Investors in the 2nd quarter worth approximately $665,997,000. Bank of New York Mellon Corp bought a new stake in National Health Investors during the 2nd quarter valued at $122,509,000. Norges Bank acquired a new position in National Health Investors during the 4th quarter worth $55,301,000. Freestone Grove Partners LP acquired a new position in National Health Investors during the 4th quarter worth $21,869,000. Finally, Adage Capital Partners GP L.L.C. bought a new position in shares of National Health Investors in the fourth quarter worth $19,856,000. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.